Author Guidelines

Information for Authors – Updated April 4, 2011

 

ABOUT JBMR

The JBMR publishes highly competitive original manuscripts, reviews, and special articles in basic and clinical science relevant to bone and mineral metabolism. Manuscripts are published in all areas of the biology and physiology of bone, the hormones that regular bone and mineral metabolism, and the pathophysiology and treatment of disorders of bone and mineral metabolism.

The JBMR is the official journal of the American Society for Bone and Mineral Research and is published on the Society’s behalf by Wiley-Blackwell. The JBMR has consistently had the highest impact factor among bone journals and ranks in the top 4% of all journals for which impact factors are calculated. The Journal’s current impact factor for is 7.056.

Manuscripts may be submitted at http://mc.manuscriptcentral.com/asbmr. Before submitting a manuscript to the JBMR, authors should carefully review the “Editorial Policies” section of this document, paying particular attention to the section on authorship and acknowledgement of contributors and disclosure of financial conflicts of interest.

Detailed instructions on how to submit a manuscript to the JBMR, including requirements for each section, format, nomenclature, tables, figures and images, are provided in the section of this document entitled “Preparation and Submission of Manuscripts to the JBMR.” Manuscripts that do not conform to the JBMR’s policies or requirements, including requirements for manuscript organization, format, and figure and image size and quality will be returned to the authors without review.

All authors must sign a JBMR Author Agreement. Manuscript submissions are not considered complete until a signed agreement has been uploaded along with the manuscript.

REVIEW PROCESS AND DECISIONS

The JBMR receives over 800 submissions annually and must therefore be highly selective, publishing only papers those judged to be of the highest scientific or clinical importance. The editors typically accept no more than 33% of the manuscripts submitted each year. Manuscripts that the editors judge unlikely to be accepted may be returned to the authors without peer review, usually within 10 days of submission. For those manuscripts sent for peer review, the typical time to initial decision is 35-40 days. All decisions are communicated to the corresponding author via email.

Note that the editors consider basic, clinical, and translational manuscripts equally; there are no preferences or quotas for any type of manuscript. All manuscripts selected for review are evaluated by 1-3 (typically two) peer experts chosen by the editors or suggested by the authors. Criteria for acceptance of a manuscript include the quality and originality of the research, excellence in the writing and organization of the manuscript, and the priority and importance of the manuscript to readers of the JBMR. Revised manuscripts must be resubmitted with three months of receipt of the JBMR’s decision letter and are ordinarily re-evaluated by the same reviewers who considered the original submission.

After acceptance, the time to online publication of the non-copy edited “Accepted Article” version of paper is typically two weeks. Time to print publication can be as long as six months after acceptance. These times assume that authors have met all requirements set out in this document, paid all relevant fees, completed all required forms, and responded to any inquiries from the editorial office.

TYPES OF MANUSCRIPTS PUBLISHED

Original Articles
The primary material published in the JBMR is original research describing regulatory factors and pathways, genetics or epidemiology related to the physiology and pathophysiology of bone, cartilage and mineral homeostasis. Original articles should be kept to within approximately 24 double-spaced pages of 12-point Times Roman text, including the text of the manuscript, references, figure legends, and tables. This is equivalent to approximately 8 pages in the Journal.

Clinical Trials
Clinical trials are original research studies that answer specific questions about novel therapies or new uses of established therapeutic agents. JBMR will consider manuscripts in this category for all phases of clinical trials. Manuscripts reporting clinical trials should be kept to within approximately 24 double-spaced pages of 12-point Times Roman text, including the text of the manuscript, references, figure legends, and tables. This is equivalent to approximately 8 pages in the Journal. Authors submitting manuscripts that report clinical trials, please note that the JBMR has special requirements for such manuscripts. See “Clinical Trials” in the Policies section of Information for Authors.

Short Reports
Short Reports are brief descriptions of a focused study, the subject of which is especially timely or of high impact in the field of bone and mineral research. Such communications should succinctly describe a particular result in 1,500-1,800 words (12-point Times Roman) and include no more than two supporting figures or tables and 20 references. Short Reports are subject to full peer review.

Case Reports & Clinical Vignettes
Case reports and clinical vignettes are discrete articles that provide highly significant insight into the pathophysiology of disorders of bone and mineral metabolism and/or highlight practical diagnostic / therapeutic considerations.

Letters to the Editor
Letters to the Editor concern timely and important issues raised in articles previously published fielding the JBMR. All Letters are forwarded to the authors of the original article following an initial editorial review in order to provide an opportunity for a response to appear along with the submitted letter. Note that the JBMR only considers Letters to the Editor that are primarily about papers previously published in the Journal. Letters should be no more than 900 words (12-point Times Roman).

Reviews and Mini-Reviews (Perspectives)
The JBMR publishes reviews and mini-reviews on topics selected by the editors. Full Reviews are approximately 6,000 words in length and Mini-Reviews (Perspectives) are approximately 2,800 words. Unsolicited reviews are rarely published. Authors should not submit reviews or perspectives without first contacting the ASBMR publications office.

Commentaries
Commentaries are manuscripts of 500 or fewer words (12-point Times Roman) that reflect on an article or articles published in the JBMR. One figure may be included. Commentaries are invited by the editors and unsolicited commentaries are rarely published in the Journal. Authors should not submit commentaries without first contacting the JBMR Editorial Office (email: jbmroffice@wiley.com).

EDITORIAL POLICIES

Copyright
The JBMR is the official journal of the American Society for Bone and Mineral Research (ASBMR), which holds copyright to all material published in the Journal except as noted in the Author Agreement.

Duplicate/Redundant Publication
The corresponding author is responsible for ensuring that the manuscript – including all data, figures, tables and supplementary materials – has not been previously reported or published. Further, it is the responsibility of the corresponding author to ensure that the manuscript has not been, and will not be, submitted to another journal while under review by the JBMR.

If any authors involved are aware of any related manuscript or other report, published or unpublished (e.g. another manuscript resulting from the same study), a copy of the related material must be sent along with the manuscript that is being submitted for publication in JBMR. Publication of preliminary data in the form of a meeting abstract is not considered duplicate publication unless the abstract exceeds two pages in length or is cited in PubMed.

Authorship and Acknowledgement of Contributors
The JBMR has adopted the requirements for authorship and acknowledgement of contributors recommended by the International Committee of Medical Journal Editors (ICMJE) in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, April 2010 update. All manuscripts submitted to the JBMR must adhere to the following requirements with regard to listing of authors and acknowledgement of contributors:

• Those listed as authors must have each 1) made substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; 2) participated in drafting the manuscript or revising it critically for important intellectual content; and 3) approved the final version of the submitted manuscript.

• All individuals who meet conditions 1, 2, and 3 must be listed as authors of the submitted manuscript.

• The respective roles of each author must be summarized in the Acknowledgements section of the manuscript.

• One or more of the authors must accept responsibility for the integrity of the data analysis and that author/those authors must be identified as such in the Acknowledgements section of the manuscript.

• All persons who have made substantial contributions to the work reported in the manuscript (e.g., data collection, analysis, writing or editing assistance) but who do not fulfill the requirements for authorship specified above must be named, with their specific contributions, in the Acknowledgements section of the manuscript.

• The authors must obtain the permission of all those who are identified in the Acknowledgements section of the manuscript.

• One author will serve as the primary correspondent (corresponding author) for the manuscript; the corresponding author is responsible for transmitting the editors’ comments to his or her co-authors.

Authors should note that the JBMR has adopted the following statement of policy based on a similar statement in the Information for Authors of the Annals of Internal Medicine:

Medical writers and pharmaceutical industry employees can be legitimate contributors to a manuscript. It is, however, particularly important that the roles, affiliations, and any potential conflicts of interest of all such contributors be included in the Acknowledgments section of the manuscript when it is submitted to the JBMR. The editors consider that failure to acknowledge such contributors constitutes ghost authorship, which is contrary to the editorial policy of the JBMR.

Disclosures/Conflict of Interest
Every paper published in the JBMR includes a “Disclosures” section. All authors must disclose all financial relationships with any organization or other entity that might be perceived to have influenced the objectivity or integrity of the work being reported in the manuscript. These disclosures must cover the 36-month period prior to submission of the manuscript to the JBMR. Such relationships include employment, research funding, income (e.g., fees for consulting, expert testimony, or speaking), or ownership interests (e.g., stock, patents) in or from an organization that may gain or lose financially from the work being submitted for publication. Disclosures must be included at the time the manuscript is initially submitted to the JBMR.

For details, please see the JBMR “Author Guide to Conflict of Interest and Other Disclosures,” which is the final section of this document. Authors should read this guide before submitting a manuscript to the Journal.

Clinical Trials
Clinical trials submitted for publication in the JBMR must conform to the “Principles for Protecting Integrity in the Conduct and Reporting of Clinical Trials” published by the American Association of Medical Colleges (AAMC). The AAMC “Principles” are available in PDF from the following page on the AAMC web site: https://www.aamc.org/initiatives/clinicalresearch/clinicaltrialsreporting/

Authors should carefully read the AAMC “Principles” to ensure that their manuscripts are in full compliance, noting in particular the following:

• Authors of clinical trial manuscripts must indicate, in the cover letter, whether the study has conformed to a pre-specified analysis.
• Authors of clinical trial manuscripts must agree to provide the protocol and pre-specified analysis plan, along with amendments to and deviations from the plan, if requested by the JBMR editors.
• Any study for which recruiting started on or after January 1, 2006, must have been registered at ClinicalTrials.gov (see www.clinicaltrials.gov). Registration must include the minimum amount of trial information as defined by the World Health Organizations (WHO) Trial Registration Data Set (see www.who.int/ictrp/network/trds/en/index.html)

Human Subjects/Declaration of Helsinki
Research carried out with human subjects must comply with the World Medical Association Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. A statement to this effect must appear in the Methods section of the manuscript, including the name of the body that gave approval. Identifying information of human subjects within written descriptions, photographs, or pedigrees should not be published. Additionally, clinical research studies must be registered with the appropriate national body. (See www.wma.net/en/30publications/10policies/b3/17c.pdf).

Use of Animals in Research
In order to be considered for publication in the JBMR, research carried out on living, non-human subjects must be in compliance with the guiding principles in the Guide for the Care and Use of Laboratory Animals: Eighth Edition, ISBN-10: 0-309-15396-4 (see www.nap.edu/catalog.php?record_id=12910). Approval by the appropriate institutional animal care and oversight committee must be indicated in the Methods.

Availability/Disclosure of Materials and Methods and Author Access to Data
Authors of papers submitted to the JBMR must make materials and methods (e.g. cell lines, hybridomas, DNA clones, antibodies, biological reagents, and animal models) described in articles published in the JBMR available to scientists in non-commercial institutions for purposes of replicating reported studies. Additionally, any original nucleotide/amino acid sequence data presented in a manuscript must be submitted to GenBank (see www.ncbi.nlm.nih.gov/genbank/index.html) by the authors, and the accession numbers must be included with the submitted manuscript.

Authors must disclose any restrictions on availability of materials, including experimental animals, used in the study and provide information on how other researchers may obtain these materials. Examples: Requests for material x [or animal x] should be addressed to [contact information] or The authors do not have permission for access to material x [or animal x] and requests for access should be directed to [contact information].

In addition, authors must disclose any restrictions on access to raw data or statistical analyses.

Plagiarism and Image Integrity
The JBMR now utilizes Ithenticate to check submitted manuscripts to ensure that the text has not been plagiarized. Figures will also be scrutinized by the editors to ensure that images have not been inappropriately manipulated.

Scientific Misconduct
If an author violates any of the JBMR’s policies described above, the Editors may reject the manuscript, impose a moratorium on the consideration of new manuscripts from the authors, or issue a statement of concern or retract an already-published article. In addition, the Editors may contact the Office of Research Integrity or an official at the authors’ home institution.

Author Agreement
The JBMR requires that all authors sign the Journal’s Author Agreement. For employees of the US National Institutes of Health (NIH), the JBMR will accept the NIH Publishing Agreement in lieu of the standard JBMR Author Agreement.

NIH Public Access Policy Compliance
For authors who indicate during the submission process that their work was funded by the US National Institutes of Health (NIH), the JBMR will post the accepted version of articles to PubMed Central upon publication. The accepted version is the version that incorporates all amendments made during peer review, but prior to the publisher’s copy-editing and typesetting. This accepted version will be made publicly available 12 months after publication. The NIH mandate applies to all articles based on research that has been wholly or partially funded by the NIH and that are accepted for publication on or after April 7, 2008.

PREPARATION AND SUBMISSION OF MANUSCRIPTS TO THE JBMR

This section presents detailed instructions on how to prepare and submit a manuscript to the JBMR. Questions may be addressed to the JBMR Editorial Office (email: jbmroffice@wiley.com).

Manuscript Categories
Manuscripts must be submitted to the JBMR via the Journal’s online submission system by a single corresponding author (submit manuscripts at http://mc.manuscriptcentral.com/asbmr). Only the designated corresponding author will be able to view the submission’s status or make changes to the manuscript; if you change the corresponding author during submission, the manuscript will be removed from your account and placed into theirs. There can be only one corresponding author per manuscript.

JBMR asks authors to classify their manuscript at the time of submission as Basic, Clinical, or Translational:

• Basic: a study limited to in vitro studies of cell biology, molecular biology, etc..
• Clinical: a study with the major component of the work involving human subjects, even if some parts of the study involve laboratory tests including genotyping, pathology, etc..
• Translational: any study involving predominantly animal models or where the laboratory and clinical aspects of a human study are of approximately equal weight.

Manuscripts submitted to the JBMR must be as DOC or DOCX files and figures must be TIF or EPS files.

Manuscript Details
Your manuscript must be submitted as a DOC or DOCX file, and should be formatted in 12-point, Times New Roman font, doubled-spaced with 1-inch margins. The manuscript file may include tables and figure legends. Figures must be submitted separately. All manuscript pages must be numbered consecutively in the bottom right-hand corner, including references, tables, and figure legends.

Nomenclature
Abbreviations and nomenclature must follow the recommendations of the International Union of Pure and Applied Chemistry and the International Union of Biochemistry. Use of the International system of Units (SI units) is required; include appropriate conversion factors to aid the reader where appropriate. Drug names should always be generic.

Papers on or that make use of bone histomorphometry must use the nomenclature, symbols, and units described in:

Parfitt, A M, Drezner, M K, Glorieux, F H, Kanis, J A, Malluche, H, Meunier, P J, Ott, S M, Recker, R R. Bone Histomorphometry : Standardization of Nomenclature, Symbols, and Units: Report of the ASBMR Histomorphometry Nomenclature Committee, J Bone Miner Res. 1987;6: 595–610. (Free full text available from http://onlinelibrary.wiley.com/doi/10.1002/jbmr.5650020617/pdf).

Papers on or that make use of of micro–computed tomography (μCT) derived bone morphometry and density measurements must cite and use the nomenclature, symbols, and units described in:

Bouxsein, M L, Boyd, S K, Christiansen, B A, Guldberg, R E, Jepsen, K J Müller, R. Guidelines for assessment of bone microstructure in rodents using micro–computed tomography. J Bone Miner Res. 2010;25: 1468–1486. (Free full text available from http://onlinelibrary.wiley.com/doi/10.1002/jbmr.141/full).

Papers on tumor necrosis factor (TNF) must use the nomenclature described in:

Proposed Standard Nomenclature for New Tumor Necrosis Factor Family Members Involved in the Regulation of Bone Resorption. 2000; J Bone Miner Res. 15: 2293–2296. (Free full text available from http://onlinelibrary.wiley.com/doi/10.1359/jbmr.2000.15.12.2293/full).

Figures
Figures must be submitted as TIF or EPS files, preferably consolidated within a single file. The JBMR cannot accept figures in PDF, PPT or PPTX formats because the quality of print reproduction of figures in these formats is poor. Manuscripts should contain no more than 7 primary figures. Tables do not count against this limit.

Supplemental material
Supplemental material must be uploaded separately from the manuscript and figures. Supplemental material will be available only in the online versions of article. Unless specifically requested by the editors during the review process, supplemental must be submitted along with the manuscript and not after the peer review process has begun or has been completed.

At the end of a successful submission the corresponding author will be required to view and approve your manuscript, at which point this author will receive an email assigning the submission a manuscript number. Make note of this number so it can easily be referenced on forms and in any communications between the authors and the editors or the ASBMR publications office.

ORGANIZATION AND FORMAT OF MANUSCRIPTS
The order of manuscript elements is as follows:

• Cover Letter
• Title Page
• Disclosure Page
• Abstracts
• Introduction
• Materials and Methods
• Results
• Discussion
• Acknowledgements
• References
• Figure Legends
• Tables
• Figures
• Supplemental Data

Descriptions of each manuscript element are provided below.

Cover Letter
The cover letter should briefly outline the major findings of the study and the potential significance of these findings in the fields of bone and mineral research. Additionally, the authors may elect to indicate suggested reviewers in their letter, along with any reviewers to whom they might be opposed. Although these requests will be taken under consideration, the JBMR editors reserve the right to select any reviewer deemed appropriate by our editorial staff to ensure a timely and accurate peer review.

Title Page
The title page must include the title, names of the authors (in appropriate order) and their major degrees, and affiliations and grant supporters. An address for reprint requests, as well as the corresponding author’s telephone number and email address, must also be provided. Finally, this page must indicate if any supplemental data has been included with the submission. Note that the JBMR does not ordinarily allow the names of co-authors to be added once a manuscript is in peer review or after acceptance.

Important: All those listed as authors must meet the requirements specified in the “Authorship” section under “Policies,” above. All those who qualify for authorship must be listed.

Disclosure Page
Immediately following the title page, all authors must disclose any financial relationships in the 36 months prior to submission of the manuscript with any organization or other entity that might be perceived to have influenced the objectivity or integrity of the work being reported. Such relationships include employment, research funding, income (e.g., fees for consulting, expert testimony, or speaking), or ownership interests (e.g., stock, patents) in or from an organization that may gain or lose financially from the work being submitted for publication. Disclosures must be included at the time the manuscript is initially submitted to the JBMR.

For details, please see the JBMR “Author Guide to Conflict of Interest and Other Disclosures,” which is the final section of this document. Authors should read this guide before submitting a manuscript to the Journal.

If none of the authors have financial disclosures, authors must include the following statement in disclosure section of the manuscript: “All authors state that they have no conflicts of interest.”

In addition, authors must disclose all restrictions on full access for all authors to all raw data, statistical analyses, and material used in the study reported in manuscripts submitted to the JBMR. For details, please see “Availability/Disclosure of Materials and Methods and Author Access to Data”.

Abstract
An abstract that briefly summarizes the major findings of the study must be included. It must be unstructured (i.e. there should not be introduction, methods, results sections, etc.), self-explanatory (i.e., completely understandable without reference to the text of the manuscript), and must not exceed 300 words. Five key words should be listed at the bottom of the Abstracts page.

Introduction
This section should concisely review the rationale for the study and identify what issues were to be addressed. Background information directly pertaining to and necessary for the understanding of, the study should also be included. This should clearly place the article within the area being studied and should not describe the outcome of the study in any detail.

Materials and Methods
This section should carefully describe the methods and materials used, including sample size and statistical approaches. It is not necessary to describe commonly used techniques in detail. Unique experiments must be outlined well enough to allow repetition by others, including sequence and source of unique constructs. Any limitation of authors to full data access (blinded, etc.) must be explained. Restrictions on access to materials or experimental animals should be specified (for details, see “Availability/Disclosure of Materials and Methods and Author Access to Data”).

Results
This section should succinctly state the results without lengthy discussion or interpretation of individual data. Graphical format is preferable to tabular presentation of data. Data in text or tables should be shown to numbers of significant digits consistent with the accuracy of each individual measurement and biological relevance.

Discussion
Study results should be summarized, though not repeated in detail, to provide context for logical explanations of the reported results and extrapolations or hypotheses drawn from them. The Discussion should conclude by re-stating the major findings of the study in relation to the rationale and aims of the study as outlined in the introduction. A concluding remark regarding wider implications of study findings is expected.

Acknowledgements
Authors must acknowledge all support for the work, including funding, materials, equipment, drugs, technical assistance, etc. Acknowledgements should conform to the requirements detailed above, in the “Policies/Contributors” section.

In addition, the JBMR requires that each author briefly summarize his or her respective role. Example:

Authors’ roles: Study design: TC and DD. Study conduct: RF. Data collection: AF. Data analysis: RF and AF. Data interpretation: TC, DD, RF, and AF. Drafting manuscript: TC and DD. Revising manuscript content: RF, and AF. Approving final version of manuscript: TC, DD, RF, and AF. RF takes responsibility for the integrity of the data analysis.

For additional examples, please see recent issues of the JBMR.

References
Authors are responsible for the accuracy of their references. References must be numbered consecutively in the order they are first mentioned. Place each reference number in parentheses, throughout the text, tables, and legends. Use parenthetical superscripts, as in this example(1). If the same reference is used again, re-use the original number.

In the Reference section of the manuscript, references must be listed in numerical order as they appear in the text. The JBMR has adopted the US National Library of Medicine (NLM) reference format as published in Citing Medicine, 2nd Edition (2007). See www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=citmed. Note that the JBMR does not limit the number of authors listed in references (i.e., does not support the use of “et al.”).

The popular reference formatting software systems “Reference Manager” and “EndNote” both support the NLM style.

Figure Legends
A separate list of figure legends must be supplied at the end of the manuscript. These should be brief and not restate information already in the Materials and Methods section. Do not include these legends in the figure files themselves.

 

Supplemental Material
Supplemental material may be submitted to accompany an article for online-only publication when there is insufficient space or it is not possible to include the material in print. Supplemental material must be important to the understanding and interpretation of the article and should not repeat material from the submission. All supplemental material must be submitted along with the manuscript. The JBMR will not accept supplemental material after an article has been accepted.

Tables
Tables should complement the text without reiterating it. All necessary information should be contained in the caption, and the table itself must be understandable independently from the text. Tables should not contain color. Provide each table column with an appropriate heading, and indicate clearly any units of measurement in the table. A key should be provided in the caption for any symbols used. Tables may be embedded into the manuscript DOC or DOCX file. Superscript notation using sequential letters to indicate statistical significance (e.g., 342 ± 14a) is preferable to the use of non-sequential symbols

Figures
Each figure should consist of no more than 4 panels. Figures should be labeled with Arabic numerals (Figure 1, 2, etc.) and panels labeled with letters (A, B, C). JBMR allows the use of videos as primary figures; in order to do so, you must submit a screen capture from the video for use in the printed version of the Journal. The y-axis of graphs should originate at 0 or should show a clear scale break in cases where this would be difficult.

Images presented in figures must adhere to the following policies, adopted from the Journal of Cell Biology (see http://jcb.rupress.org/site/misc/ifora.xhtml):

    • No specific feature within an image may be enhanced, obscured, moved, removed, or introduced.

    • The grouping of images from different parts of the same gel, or from different gels, fields, or exposures must be made explicit by the arrangement of the     figure (i.e., using dividing lines) and in the text of the figure legend.

    • Adjustments of brightness, contrast, or color balance are acceptable if they are applied to the whole image and as long as they do not obscure, eliminate,     or misrepresent any information present in the original, including the background. Non-linear adjustments (e.g., changes to gamma settings) must be     disclosed in the figure legend.

    • For a more detailed discussion of image presentation, see Rossner, M. Yamada, K.M. What's in a picture? The temptation of image manipulation. J Cell     Biol. 2004; 166: 11-15. (free full text available from http://jcb.rupress.org/content/166/1/11.full).

Figures must not be embedded into a DOC or PDF file, and figures should not include figure legends. Figures must be submitted in TIF or EPS formats. See the “Digital Expert” web site of the Sheridan Press for information on quality, size, and file types for figures (see     http://dx.sheridan.com/index.html).

ONLINE OPEN
OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley Online Library, as well as deposited in the funding agency's preferred archive. For the full list of terms and conditions, see http://olabout.wiley.com/WileyCDA/Section/id-406241.html.

If you wish your paper to be OnlineOpen you are required to complete the OnlineOpen payment form available from our website at:
https://onlinelibrary.wiley.com/onlineOpenOrder. The author’s fee for OnlineOpen in JBMR is $3,000 US. OnlineOpen will be activated upon payment and can be ordered at any point prior to, or after, acceptance.
 

COVER IMAGES
Authors wishing to submit images for consideration for use on the front cover of the JBMR are welcome to do so. Images and questions regarding cover images should be emailed to jbmrart@yahoo.com.

PUBLICATION FEES

Submission Fee
The JBMR charges a fee of $50.00 US for all unsolicited submissions with the exception of revised manuscripts, invited reviews and commentaries, and Letters to the Editor.

Page Fees
Page charges for published manuscripts are $60 per page up to 8 pages and $120 per page for the 9th and all subsequent pages. Instructions for payment will be sent to authors along with the proofs. Invited material is not subject to page fees.

Color Figure and Image Fee
The JBMR charges $900.00 US per page of color figures. In many cases, multiple color figures can be fit onto the same page, reducing this charge. Figures must be consistent in all published versions; the JBMR does not offer online-only color publication. Instructions for payment will be sent to authors along with the e-proofs of papers accepted for publication. Invited material is not subject to color charges.

JBMR AUTHOR GUIDE TO CONFLICT OF INTEREST AND OTHER DISCLOSURES
Every paper published in the JBMR includes a “Disclosures” section in which all authors must disclose any financial relationships in the 36 months prior to submission of the manuscript with any organization or other entity that might be perceived to have influenced the objectivity or integrity of the work being reported. These relationships include employment, research funding, income, or ownership interests in or from an organization that may gain or lose financially from the work being submitted for publication. Disclosures must be included at the time the manuscript is initially submitted to the JBMR.

Authors should consult the JBMR Disclosure Checklist (below) for details on relationships that must be disclosed in manuscripts submitted to the JBMR. It is not necessary to submit this form to the JBMR. However, the ASBMR Publications Office strongly encourages all authors to carefully review and complete this checklist as a guide to preparing the “Disclosures” section of manuscripts submitted to the Journal.

If any of the authors have financial conflicts to disclose, this information must be included in the “Disclosures” section of the manuscript being submitted, which appears immediately prior to the “Acknowledgements” and “References” sections. Examples of disclosure statement language are as follows:

Author is an employee of company; author is a member of the advisory council for company; author has received speaking fees from company; author has provided expert testimony for company; author owns stock in company; author has received research funding from company.

If none of the authors have financial disclosures, authors must include the following statement in disclosure section of the manuscript: “All authors state that they have no conflicts of interest.”

In addition to financial relationships, authors must disclose any limitations on access to data or other materials critical to the work being reported. For details, see “Availability/Disclosure of Materials and Methods and Author Access to Data”.

 

JBMR Disclosure Checklist

For information on the use of this checklist, please see the JBMR Author Guide to Conflict of Interest and Other Disclosures.
 

Relationship	Yes	No	If yes, identify organization or other entity
Board membership: Have you served as a paid board member with any entity related to the work reported in the manuscript?
Consulting: Have you received consulting fees for any entity related to the work reported in the manuscript?
Employment: Have you been employed by any entity related to the work reported in the manuscript?
Expert testimony: Have you served as an expert witness or advisor in legal proceedings for any entity related to the work reported in the manuscript?
Honoraria/Royalties: Have you received honoraria or royalties connected to any entity related to the work reported in the manuscript?
Grants and Contracts: Have you received grants for research from any entity related to the work reported in the manuscript?
Spokesperson/Speakers Bureau: Have you served as a paid spokesperson for any entity related to the work reported in the manuscript?
Stock/Stock Options: Do you or a household member have any equity ownership or stock options in any entity related to the work reported in the manuscript? Note: this does NOT include diversified mutual funds in which the author does not directly control the purchase or sale of equities; these forms of equity ownership do not need to be disclosed.
Ownership/Patents: Do you have any ownership interest, including patents, whether filed for or received, for anything related to work reported in the manuscript?

 

 

Site Footer

• Privacy Policy
• Terms of Service
• Copyright
• Wiley.com